Yuewei Medical, Portfolio Company of Hetang Venture Capital, Completes Nearly RMB 100 Million Financing to Strengthen Cardiovascular Surgery Portfolio
Yellwin
Cardiac Surgery Implantable Medical Device R&D Provider
Recently, Hetang Ventures invested in a company —— Yellwin (short for "Beijing Yellwin Medical Technology Co., Ltd.")Yellwin"), announced the completion of nearly 100 million yuan in equity financing. This round of financing was led byYifeng Capital Leads Investment, Followed by Beishang Capital and Bohai Chuangfu.
This is the second large-scale financing completed by the company within the year, fully demonstrating the high recognition of the capital market for the company's development process.Through this round of financing, Yellwin will continue to comprehensively strengthen its R&D innovation and market penetration capabilities in cardiovascular surgery and other extended fields, further consolidating its leading position.
Yellwin was founded inIn September 2021, Yellwin was established with its headquarters in Beijing. Based on the founding team's extensive clinical experience, the company identifies clinical needs and develops multiple globally or domestically pioneering medical devices that fill market gaps, while also considering the current state of related fields. Currently, the company has two major self-developed product lines: coronary surgery, critical care, and extracorporeal circulation, encompassing nearly 10 products. Among them, the ultrasonic vascular flow measurement system, pulsatile left ventricular assist system, and dual-lumen jugular catheter are all pioneering products in China.
While deeply cultivating its core business and solidifying its competitive advantages, the company possesses strong capabilities for business expansion and merger integration.In 2025, Yellwin expanded its DVT product line through mergers and acquisitions, including two innovative medical devices, both of which have entered the registration clinical stage, further solidifying its leading position in the industry.
For more details, please click [Read Original] below.
The content of this article is reprinted fromYellwinOfficial Account
About Hetang Ventures
Hetao Venture Capital is a venture capital fund management institution held by Beijing Tsinghua Industrial Development Research Institute,Restructured in 2014 under the strategic backdrop of promoting the transformation of scientific and technological achievements in universities, Hotang Ventures is a professional investment management institution primarily focused on early-stage investments in science and technology innovation enterprises. Hotang Ventures concentrates on key fields such as life sciences, medical devices, information technology, and modern manufacturing. It has long been dedicated to investing in innovative enterprises with core hard technologies, while also specializing in incubating investments from scientific and technological achievements by university and top-tier hospital clinical experts. Hotang Ventures currently manages funds totaling nearly 4 billion yuan, with over 100 accumulated investment projects. It supports scientists and entrepreneurs with significant research discoveries and technological innovations in implementing their results, achieving "commercial transformation from 0 to 1." At the same time, it consistently adheres to selecting high-barrier "first-of-its-kind technologies" for early-stage investment. With outstanding performance, Hotang Ventures has received honors such as being ranked in the “Top 50 Early Investment Institutions in China” by Rongzhong and “Top 50 Best Early Venture Capital Institutions in China” by Touzhong.
